Pay in 4 interest-free payments of $5.08 Learn more
%25201.png)
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
GLP-1, GIP & Inflammation: What These Medications Really Do and What They Dont Joshua Silva, MD Dec 5, 2025 7 min read Updated: Jan 27 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Quick Answer GLP-1 and GLP-1/GIP medications (such as semaglutide and tirzepatide ) can lower metabolic inflammation by improving insulin resistance, reducing visceral fat, and lowering inflammatory biomarkers such as C-reactive protein (CRP) ., They can also improve cardiometabolic risk markers (e.g., blood pressure) and, for tirzepatide, can improve atherogenic lipoprotein measures including apoB and triglyceride-rich lipoproteins in clinical research settings., They do not treat autoimmune diseases or fibromyalgia directly
Patient C: Jessica, 34, with a BMI of 31 and PCOS
We simplify the process, support their journey from all angles, and help them make the most of their benefits for long-term success
By suppressing appetite and delaying gastric emptying, GLP-1RAs chronically reduce nutrient delivery from the diet [53]
Duarte, C
